临床阶段-话题@MedSci - 梅斯（MedSci）

#临床阶段#

10篇内容 | 1203人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=2185464, encodeId=1454218546446, content=<a href='/topic/show?id=6b8a230e815' target=_blank style='color:#2F92EE;'>#临床阶段#</a> <a href='/topic/show?id=2709110810e0' target=_blank style='color:#2F92EE;'>#自体T细胞疗法#</a>, objectTitle=Thermo Fisher Scientific与Arsenal Biosciences合作，支持自体T细胞疗法的临床制造, objectType=article, longId=764959, objectId=3ba5e6495923, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/20230326/1679884688036_4754896.png, objectUrl=/article/show_article.do?id=3ba5e6495923, replyNumber=0, likeNumber=0, createdTime=2024-02-02, rootId=0, userName=梅斯管理员, userId=cade5395722, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=上海, moduleDTOList=[ModuleDTO(moduleId=3ba5e6495923, moduleTitle=Thermo Fisher Scientific与Arsenal Biosciences合作，支持自体T细胞疗法的临床制造, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=3ba5e6495923)], followStatus=false, userIsMember=false, type=null, lengthMark=0), GetTopicListResponse(id=2025286, encodeId=f9842025286a8, content=<a href='/topic/show?id=6b8a230e815' target=_blank style='color:#2F92EE;'>#临床阶段#</a>, objectTitle=Rhizen Pharmaceuticals AG宣布即将在ESMO 2022上展示其临床阶段的资产数据；Tenalisib治疗局部晚期/转移性乳腺癌和RP12146治疗多种实体瘤, objectType=article, longId=739183, objectId=460ce39183f7, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=460ce39183f7, replyNumber=0, likeNumber=156, createdTime=2023-02-27, rootId=0, userName=lixiao3326, userId=d39f177, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=460ce39183f7, moduleTitle=Rhizen Pharmaceuticals AG宣布即将在ESMO 2022上展示其临床阶段的资产数据；Tenalisib治疗局部晚期/转移性乳腺癌和RP12146治疗多种实体瘤, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=460ce39183f7)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2025285, encodeId=eb612025285f5, content=<a href='/topic/show?id=6b8a230e815' target=_blank style='color:#2F92EE;'>#临床阶段#</a>, objectTitle=Cell | 人类病理性Tau蛋白的翻译后修饰图谱可区分阿尔兹海默症的临床阶段, objectType=article, longId=291369, objectId=507a29136935, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=507a29136935, replyNumber=0, likeNumber=72, createdTime=2022-05-25, rootId=0, userName=lixiao3326, userId=d39f177, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=507a29136935, moduleTitle=Cell | 人类病理性Tau蛋白的翻译后修饰图谱可区分阿尔兹海默症的临床阶段, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=507a29136935)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2025284, encodeId=41b3202528436, content=<a href='/topic/show?id=6b8a230e815' target=_blank style='color:#2F92EE;'>#临床阶段#</a>, objectTitle=武田和Frazier Healthcare Partners宣布合作成立HilleVax, Inc.以开发临床阶段诺如病毒候选疫苗, objectType=article, longId=215179, objectId=45d52151e9f8, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=45d52151e9f8, replyNumber=0, likeNumber=92, createdTime=2021-08-12, rootId=0, userName=lixiao3326, userId=d39f177, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=45d52151e9f8, moduleTitle=武田和Frazier Healthcare Partners宣布合作成立HilleVax, Inc.以开发临床阶段诺如病毒候选疫苗, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=45d52151e9f8)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2025281, encodeId=611b20252812b, content=<a href='/topic/show?id=6b8a230e815' target=_blank style='color:#2F92EE;'>#临床阶段#</a>, objectTitle=防御南非变种！Moderna的变异特异性COVID-19候选疫苗即将进入临床阶段, objectType=article, longId=207592, objectId=d9be20e59233, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=d9be20e59233, replyNumber=0, likeNumber=67, createdTime=2022-01-14, rootId=0, userName=lixiao3326, userId=d39f177, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=d9be20e59233, moduleTitle=防御南非变种！Moderna的变异特异性COVID-19候选疫苗即将进入临床阶段, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=d9be20e59233)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2025283, encodeId=38882025283e8, content=<a href='/topic/show?id=6b8a230e815' target=_blank style='color:#2F92EE;'>#临床阶段#</a>, objectTitle=临床阶段生物制药公司宣布开展卡妥索双抗治疗非肌层浸润性膀胱癌临床I/II期试验, objectType=article, longId=209970, objectId=4f092099e063, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=4f092099e063, replyNumber=0, likeNumber=69, createdTime=2021-08-08, rootId=0, userName=lixiao3326, userId=d39f177, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=4f092099e063, moduleTitle=临床阶段生物制药公司宣布开展卡妥索双抗治疗非肌层浸润性膀胱癌临床I/II期试验, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=4f092099e063)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2025282, encodeId=47c120252820a, content=<a href='/topic/show?id=6b8a230e815' target=_blank style='color:#2F92EE;'>#临床阶段#</a>, objectTitle=J Am Acad Child Adolesc Psychiatry：亚临床阶段强迫症CSTC连接性的改变导致成年后强迫症易感性增加, objectType=article, longId=207841, objectId=cea920e84114, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=cea920e84114, replyNumber=0, likeNumber=82, createdTime=2021-04-20, rootId=0, userName=lixiao3326, userId=d39f177, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=cea920e84114, moduleTitle=J Am Acad Child Adolesc Psychiatry：亚临床阶段强迫症CSTC连接性的改变导致成年后强迫症易感性增加, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=cea920e84114)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2025280, encodeId=b167202528023, content=<a href='/topic/show?id=6b8a230e815' target=_blank style='color:#2F92EE;'>#临床阶段#</a>, objectTitle=Sci Tran Med：突破，研究发现了“癌症疫苗”，可以消除肿瘤，已经进入临床阶段, objectType=article, longId=128474, objectId=6d721284e480, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=6d721284e480, replyNumber=0, likeNumber=77, createdTime=2018-05-03, rootId=0, userName=lixiao3326, userId=d39f177, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=6d721284e480, moduleTitle=Sci Tran Med：突破，研究发现了“癌症疫苗”，可以消除肿瘤，已经进入临床阶段, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=6d721284e480)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2025278, encodeId=196520252e823, content=<a href='/topic/show?id=6b8a230e815' target=_blank style='color:#2F92EE;'>#临床阶段#</a>, objectTitle=Otol Neurotol：口服候选临床阶段药物SENS-401可以有效的减少铂引起的听力损失, objectType=article, longId=108637, objectId=097710863e73, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=097710863e73, replyNumber=0, likeNumber=89, createdTime=2018-03-18, rootId=0, userName=lixiao3326, userId=d39f177, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=097710863e73, moduleTitle=Otol Neurotol：口服候选临床阶段药物SENS-401可以有效的减少铂引起的听力损失, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=097710863e73)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2025279, encodeId=8bc720252e997, content=<a href='/topic/show?id=6b8a230e815' target=_blank style='color:#2F92EE;'>#临床阶段#</a>, objectTitle=Sci Trans Med：乙肝新药进入临床阶段，有望彻底治愈乙肝, objectType=article, longId=119187, objectId=5dab11918e83, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=5dab11918e83, replyNumber=0, likeNumber=74, createdTime=2018-08-08, rootId=0, userName=lixiao3326, userId=d39f177, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=5dab11918e83, moduleTitle=Sci Trans Med：乙肝新药进入临床阶段，有望彻底治愈乙肝, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=5dab11918e83)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2025277, encodeId=442a20252e7d9, content=<a href='/topic/show?id=6b8a230e815' target=_blank style='color:#2F92EE;'>#临床阶段#</a>, objectTitle=葛兰素史克开发埃博拉病毒疫苗即将进入临床阶段, objectType=article, longId=39217, objectId=66243921e09, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=66243921e09, replyNumber=0, likeNumber=72, createdTime=2014-08-18, rootId=0, userName=lixiao3326, userId=d39f177, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=66243921e09, moduleTitle=葛兰素史克开发埃博拉病毒疫苗即将进入临床阶段, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=66243921e09)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] 梅斯话题小助手

临床阶段

2020-05-29

梅斯管理员 (审核中...)

前往app查看评论内容

#临床阶段# #自体T细胞疗法#

Thermo Fisher Scientific与Arsenal Biosciences合作，支持自体T细胞疗法的临床制造

2024-02-02发表于上海

lixiao3326 (审核中...)

前往app查看评论内容

#临床阶段#

Rhizen Pharmaceuticals AG宣布即将在ESMO 2022上展示其临床阶段的资产数据；Tenalisib治疗局部晚期/转移性乳腺癌和RP12146治疗多种实体瘤

2023-02-27

lixiao3326 (审核中...)

前往app查看评论内容

#临床阶段#

Cell | 人类病理性Tau蛋白的翻译后修饰图谱可区分阿尔兹海默症的临床阶段

2022-05-25

lixiao3326 (审核中...)

前往app查看评论内容

#临床阶段#

武田和Frazier Healthcare Partners宣布合作成立HilleVax, Inc.以开发临床阶段诺如病毒候选疫苗

2021-08-12

lixiao3326 (审核中...)

前往app查看评论内容

#临床阶段#

防御南非变种！Moderna的变异特异性COVID-19候选疫苗即将进入临床阶段

2022-01-14

lixiao3326 (审核中...)

前往app查看评论内容

#临床阶段#

临床阶段生物制药公司宣布开展卡妥索双抗治疗非肌层浸润性膀胱癌临床I/II期试验

2021-08-08

lixiao3326 (审核中...)

前往app查看评论内容

#临床阶段#

J Am Acad Child Adolesc Psychiatry：亚临床阶段强迫症CSTC连接性的改变导致成年后强迫症易感性增加

2021-04-20

lixiao3326 (审核中...)

前往app查看评论内容

#临床阶段#

Sci Tran Med：突破，研究发现了“癌症疫苗”，可以消除肿瘤，已经进入临床阶段

2018-05-03

lixiao3326 (审核中...)

前往app查看评论内容

#临床阶段#

Otol Neurotol：口服候选临床阶段药物SENS-401可以有效的减少铂引起的听力损失

2018-03-18

lixiao3326 (审核中...)

前往app查看评论内容

#临床阶段#

Sci Trans Med：乙肝新药进入临床阶段，有望彻底治愈乙肝

2018-08-08

lixiao3326 (审核中...)

前往app查看评论内容

#临床阶段#

葛兰素史克开发埃博拉病毒疫苗即将进入临床阶段

2014-08-18

科室
- - 订阅+
  - 更多科室
工具
服务